Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-004037
Filing Date
2020-02-06
Accepted
2020-02-06 17:19:00
Documents
1
Period of Report
2020-02-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3115
  Complete submission text file 0001127602-20-004037.txt   4542
Mailing Address 5200 ILLUMINA WAY SAN DIEGO CA 92122
Business Address 5200 ILLUMINA WAY SAN DIEGO CA 92122 8582024500
ILLUMINA, INC. (Issuer) CIK: 0001110803 (see all company filings)

EIN.: 330804655 | State of Incorp.: DE | Fiscal Year End: 1229
SIC: 3826 Laboratory Analytical Instruments

Mailing Address MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
Gottlieb Scott (Reporting) CIK: 0001411359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35406 | Film No.: 20583636